Specify a stock or a cryptocurrency in the search bar to get a summary
BioPorto
BIOPORBioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark. Address: Tuborg Havnevej 15, st., Hellerup, Denmark, 2900
Analytics
WallStreet Target Price
21.25 DKKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BIOPOR
Dividend Analytics BIOPOR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIOPOR
Stock Valuation BIOPOR
Financials BIOPOR
Results | 2019 | Dynamics |